BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18923442)

  • 1. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
    Ullmannova-Benson V; Guan M; Zhou X; Tripathi V; Yang XY; Zimonjic DB; Popescu NC
    Leukemia; 2009 Feb; 23(2):383-90. PubMed ID: 18923442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
    Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
    In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
    Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
    J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
    Liu Y; Zhou J; Hu Y; Wang J; Yuan C
    Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.
    Zhou X; Yang XY; Popescu NC
    Biochem Biophys Res Commun; 2012 Apr; 420(2):325-30. PubMed ID: 22425986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.
    Sabbir MG; Prieditis H; Ravinsky E; Mowat MR
    PLoS One; 2012; 7(7):e40302. PubMed ID: 22792269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
    Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
    J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.
    Low JS; Tao Q; Ng KM; Goh HK; Shu XS; Woo WL; Ambinder RF; Srivastava G; Shamay M; Chan AT; Popescu NC; Hsieh WS
    Oncogene; 2011 Apr; 30(16):1923-35. PubMed ID: 21217778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.
    Sabbir MG; Wigle N; Loewen S; Gu Y; Buse C; Hicks GG; Mowat MR
    BMC Biol; 2010 Mar; 8():17. PubMed ID: 20199662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells.
    Ma L; Zhu WZ; Liu TT; Fu HL; Liu ZJ; Yang BW; Song TY; Li GR
    Asian Pac J Cancer Prev; 2015; 16(4):1637-42. PubMed ID: 25743845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
    Dai Z; Jin Y
    Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
    Tripathi V; Popescu NC; Zimonjic DB
    Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
    Guan M; Tripathi V; Zhou X; Popescu NC
    Cancer Gene Ther; 2008 Jun; 15(6):371-81. PubMed ID: 18369381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.
    Zhou X; Zimonjic DB; Park SW; Yang XY; Durkin ME; Popescu NC
    Int J Oncol; 2008 Jun; 32(6):1285-91. PubMed ID: 18497990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DLC1 negatively regulates angiogenesis in a paracrine fashion.
    Shih YP; Liao YC; Lin Y; Lo SH
    Cancer Res; 2010 Nov; 70(21):8270-5. PubMed ID: 20861185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.
    Kim TY; Jackson S; Xiong Y; Whitsett TG; Lobello JR; Weiss GJ; Tran NL; Bang YJ; Der CJ
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16868-73. PubMed ID: 24082123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tensin1 positively regulates RhoA activity through its interaction with DLC1.
    Shih YP; Sun P; Wang A; Lo SH
    Biochim Biophys Acta; 2015 Dec; 1853(12):3258-65. PubMed ID: 26427649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.